Sage Journals: Discover world-class research

Open access

Review article

First published 2023

The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia

Robert Briski, Guillermo Garcia-Manero, Hagop Kantarjian [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2024

Patients’ perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms

Amer M. Zeidan, Kate Perepezko, Tehseen Salimi [...]

Therapeutic Advances in Hematology

Free access

Research article

First published 2014-3

Subchronic Oral Toxicity Study of Decitabine in Combination With Tetrahydrouridine in CD-1 Mice

Pramod Terse, Kory Engelke, Kenneth Chan [...]

International Journal of Toxicology

Open access

Research article

First published 2026

Real-world study of use patterns and clinical outcomes for patients with myelodysplastic syndrome initiating oral decitabine and cedazuridine or intravenous/subcutaneous hypomethylating agents

Amer M. Zeidan, Ruizhi Zhao, Jon G. Tepsick [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2024

Clinical activity,pharmacokinetics,and pharmacodynamics of oral hypomethylating agents for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: A multidisciplinary review

Ryan Haumschild, Julie Kennerly-Shah, Lisa Barbarotta [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2014-12

Characterization of Permeability,Stability and Anti-HIV-1 Activity of Decitabine and Gemcitabine Divalerate Prodrugs

Christine L Clouser, Laurent Bonnac, Louis M Mansky [...]

Antiviral Chemistry and Chemotherapy

Open access

Review article

First published 2020

Emerging treatment options for patients with high-risk myelodysplastic syndrome

Jan Philipp Bewersdorf, Hetty Carraway, Thomas Prebet

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2012-6

DNA Demethylating Agent Decitabine Increases AQP5 Expression and Restores Salivary Function

Y. Yamamura, K. Aota, T. Yamanoi [...]

Journal of Dental Research

Open access

Review article

First published 2019

Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy

Guillaume Richard-Carpentier, Courtney D. DiNardo

Therapeutic Advances in Hematology

Search results